An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial

Running, not enrolling · Phase 3

Conditions studied: Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, Multiple Myeloma, Non-Hodgkin's Lymphoma, Acute Lymphoblastic Leukemia, Cancer

In brief

The purpose of this extension study is to provide venetoclax and obtain long-term safety data for subjects who continue to tolerate and derive benefit from receiving venetoclax in ongoing studies.

Key facts

Study ID

NCT03844048

Run by

AbbVie

People needed

165

Starts

2019-09-06

Expected to finish

2027-08-01

Last updated by the study team

2026-05-13

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has been enrolled and dosed in an ongoing venetoclax study and continues to tolerate and derive benefit from the study drug.
• Male subject agrees to refrain from sperm donation.
• Female subjects must not be pregnant or breastfeeding.

You may not qualify if…

• None.

Where it is running

• UCLA Santa Monica Hematology Oncology /ID# 210551 — Los Angeles, California, United States
• Ingalls Memorial Hosp /ID# 210553 — Harvey, Illinois, United States
• Dana-Farber Cancer Institute /ID# 215360 — Boston, Massachusetts, United States
• University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 231132 — Ann Arbor, Michigan, United States
• Dartmouth-Hitchcock Medical Center /ID# 210555 — Lebanon, New Hampshire, United States
• Swedish Medical Center - Seattle /ID# 213120 — Seattle, Washington, United States
• Royal Prince Alfred Hospital /ID# 239557 — Camperdown, New South Wales, Australia
• St George Hospital /ID# 225589 — Kogarah, New South Wales, Australia
• Liverpool Hospital /ID# 225591 — Liverpool, New South Wales, Australia
• Peter MacCallum Cancer Ctr /ID# 210559 — Melbourne, Victoria, Australia
• Fiona Stanley Hospital /ID# 239480 — Murdoch, Western Australia, Australia
• Perth Blood Institute Ltd /ID# 225592 — Nedlands, Western Australia, Australia
• Duplicate_Medizinische Universitaet Graz /ID# 223817 — Graz, Styria, Austria
• Cliniques Universitaires UCL Saint-Luc /ID# 224327 — Brussels, Brussels Capital, Belgium
• CHUQ- Hôpital de l'Enfant-Jesus /ID# 224616 — Québec, Quebec, Canada
• Rigshospitalet /ID# 224213 — Copenhagen Ø, Capital Region, Denmark
• Aarhus Universitetshospital - Skejby /ID# 224214 — Aarhus, Central Jutland, Denmark
• CHU Grenoble - Hopital Michallon /ID# 240497 — La Tronche, Isere, France
• HCL - Hopital Lyon Sud /ID# 213508 — Pierre-Bénite, Rhone, France
• General Hospital of Athens Laiko /ID# 224087 — Athens, Attica, Greece
• General Hospital of Thessaloniki George Papanikolaou /ID# 224088 — Thessaloniki, Greece
• Queen Mary Hospital /ID# 224944 — Hong Kong, Hong Kong
• Beaumont Hospital /ID# 225165 — Dublin, Ireland
• Kobe City Medical Center General Hospital /ID# 241518 — Kobe, Hyōgo, Japan
• University of Arizona Cancer Center - Tucson /ID# 210548 — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.